Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy

Carlo Rinaldi*, Laura C. Bott, Ke lian Chen, George G. Harmison, Masahisa Katsuno, Gen Sobue, Maria Pennuto, Kenneth H. Fischbeck

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Keyphrases